-
公开(公告)号:US07642361B2
公开(公告)日:2010-01-05
申请号:US10596419
申请日:2005-01-05
申请人: Ana Maria Castano Mansanet , Esteban Dominguez-Manzanares , Ana Maria Escribano , Maria Carmen Fernandez , William Joseph Hornback , Alma Maria Jimenez-Aguado , Eric George Tromiczak , Zhipei Wu , Hamideh Zarrinmayeh , Dennis Michael Zimmerman
发明人: Ana Maria Castano Mansanet , Esteban Dominguez-Manzanares , Ana Maria Escribano , Maria Carmen Fernandez , William Joseph Hornback , Alma Maria Jimenez-Aguado , Eric George Tromiczak , Zhipei Wu , Hamideh Zarrinmayeh , Dennis Michael Zimmerman
IPC分类号: C07D333/38
CPC分类号: C07D307/68 , C07D333/38 , C07D409/10 , C07D417/10
摘要: The present invention relates to thiophene and furan compounds and their pharmaceutically acceptable salts, and further relates to their use in treating schizophrenia, cognitive deficits associated with schizophrenia, Alzheimer's disease, dementia of the Alzheimer's type, mild cognitive impairment, or depression.
摘要翻译: 本发明涉及噻吩和呋喃化合物及其药学上可接受的盐,并且还涉及它们在治疗精神分裂症,与精神分裂症相关的认知缺陷,阿尔茨海默病,阿尔茨海默氏型痴呆,轻度认知障碍或抑郁症中的用途。
-
公开(公告)号:US07749992B2
公开(公告)日:2010-07-06
申请号:US10574649
申请日:2004-10-07
申请人: Guoqing Cao , Ana Maria Escribano , Maria Carmen Fernandez , Todd Fields , Douglas Linn Gernert , Christopher Lawrence Cioffi , Robert Jason Herr , Nathan Bryan Mantlo , Eva Maria Martin De La Nava , Ana Isabel Mateo Herranz , Daniel Ray Mayhugh , Xiaodong Wang
发明人: Guoqing Cao , Ana Maria Escribano , Maria Carmen Fernandez , Todd Fields , Douglas Linn Gernert , Christopher Lawrence Cioffi , Robert Jason Herr , Nathan Bryan Mantlo , Eva Maria Martin De La Nava , Ana Isabel Mateo Herranz , Daniel Ray Mayhugh , Xiaodong Wang
IPC分类号: A61P3/06 , A61P9/10 , A61K31/55 , C07D223/14 , C07D223/16 , C07D223/32 , C07D225/06 , C07D403/04 , C07D403/12 , C07D405/06 , C07D405/12 , C07D413/04 , C07D491/04
CPC分类号: C07D223/16 , C07D223/14 , C07D223/32 , C07D225/06 , C07D403/04 , C07D403/12 , C07D405/06 , C07D405/12 , C07D413/04 , C07D491/04
摘要: Compounds of formula I wherein n, m, p, q, y, R1 R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating artherosclerosis and its sequelae.
摘要翻译: 其中n,m,p,q,y,R 1,R 2,R 3,R 4,R 5和R 6如本文所定义的式I化合物,其药物组合物和使用方法被公开用于治疗动脉粥样硬化及其后遗症。
-
公开(公告)号:US20080269284A1
公开(公告)日:2008-10-30
申请号:US11570540
申请日:2005-06-22
申请人: Ana Maria Escribano , Maria Carmen Fernandez , Nathan Bryan Mantlo , Ana Isabel Mateo-Herranz , Eva Maria Martin De La Nava , Xiaodong Wang
发明人: Ana Maria Escribano , Maria Carmen Fernandez , Nathan Bryan Mantlo , Ana Isabel Mateo-Herranz , Eva Maria Martin De La Nava , Xiaodong Wang
IPC分类号: A61K31/4709 , A61P9/00 , C07D401/12
CPC分类号: C07D401/14 , C07D401/12 , C07D403/12 , C07D403/14 , C07D405/14 , C07D413/12 , C07D417/12 , C07D491/04
摘要: Compounds of Formula I wherein n, q, Y, R1, R2a, R2b, R3a, R3b, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed.
摘要翻译: 式I的化合物,其中n,q,Y,R 1,R 2a,R 2b,R 3a, R 3b,R 4,R 5和R 6如本文所定义,并且其药物组合物和 公开了使用方法。
-
公开(公告)号:US20100204207A1
公开(公告)日:2010-08-12
申请号:US12763344
申请日:2010-04-20
申请人: Xinchao Chen , Christopher Lawrence Cioffi , Sean Richard Dinn , Ana Maria Escribano , Maria Carmen Fernandez , Todd Fields , Robert Jason Herr , Nathan Bryan Mantlo , Eva Maria Martin De La Nava , Ana Isabel Mateo Herranz , Saravanan Parthasarathy , Xiaodong Wang
发明人: Xinchao Chen , Christopher Lawrence Cioffi , Sean Richard Dinn , Ana Maria Escribano , Maria Carmen Fernandez , Todd Fields , Robert Jason Herr , Nathan Bryan Mantlo , Eva Maria Martin De La Nava , Ana Isabel Mateo Herranz , Saravanan Parthasarathy , Xiaodong Wang
IPC分类号: A61K31/55 , C07D403/12 , C07D417/12 , C07D491/048 , C07D405/14 , C07D413/12 , C07D401/14 , A61P3/00 , A61P9/10
CPC分类号: C07D401/14 , C07D401/12 , C07D403/12 , C07D403/14 , C07D405/14 , C07D413/12 , C07D417/12 , C07D491/04
摘要: Compounds of Formula (I): wherein n, m, p, q, Y, R1, R2, R3a, R3b, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed.
摘要翻译: 式(I)化合物:其中n,m,p,q,Y,R 1,R 2,R 3a,R 3b,R 4,R 5和R 6如本文所定义,并公开了其药物组合物和使用方法。
-
公开(公告)号:US07470705B2
公开(公告)日:2008-12-30
申请号:US10598473
申请日:2005-03-17
申请人: Michael Gregory Bell , Guoqing Cao , Ana Maria Escribano , Maria Carmen Fernandez , Peter Ambrose Lander , Nathan Bryan Mantlo , Eva Maria Martin de la Nava , Ana Isabel Mateo Herranz , Daniel Ray Mayhugh , Xiaodong Wang
发明人: Michael Gregory Bell , Guoqing Cao , Ana Maria Escribano , Maria Carmen Fernandez , Peter Ambrose Lander , Nathan Bryan Mantlo , Eva Maria Martin de la Nava , Ana Isabel Mateo Herranz , Daniel Ray Mayhugh , Xiaodong Wang
IPC分类号: A01N43/42 , A61K31/44 , C07D471/02
CPC分类号: C07D495/04 , C07D471/04 , C07D487/04
摘要: The present invention discloses compounds of formula (I) wherein A, n, q, K, W, X, Y; Z, R1, R2, R3, R4, R5, and R6 are as defined herein and their pharmaceutical compositions and methods of use are disclosed as useful for treating dyslipidemia and its sequelae.
摘要翻译: 本发明公开了式(I)的化合物,其中A,n,q,K,W,X,Y; Z,R 1,R 2,R 3,R 4,R 5和R 6如本文所定义,其药物组合物和使用方法被公开用于治疗血脂障碍及其后遗症。
-
-
-
-